YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity

• Päätekijät: Wing Lam (Tekijä), Rong Hu (Tekijä), Shwu-Huey Liu (Tekijä), Peikwen Cheng (Tekijä), Yung-Chi Cheng (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

YIV-906 is a systems biology botanical cancer drug, inspired by a traditional Chinese herbal formulation. Results from eight Phase I/II to II clinical studies demonstrated the potential of YIV-906 to prolong survival and improve the quality of life of cancer patients. As an immunomodulator in the tu...